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ABSTRACT  
THE CHARACTERIZATION OF CHITIN MICROPARTICLE PREPARATIONS: 
DEGREE OF ACETYLATION AND ITS EFFECT ON IMMUNOLOGIC RESPONSE 
MAY 2014 
JULIANNE R. ZIMMERMAN, B.S., UNIVERSITY OF MASSACHUSETTS M.S.	  UNIVERSITY	  OF	  MASSACHUSETTS	  AMHERST	  	  
Directed by: Professor Christine A. Rogers 	  
Studies examining the immune response upon exposure to chitin microparticles in 
living models have reached drastically differing conclusions, and the reason remains 
unclear. One notable issue between the experiments is that they have not characterized 
their chitin preparations for degree of acetylation. They all use different chitin processing 
methods prior to administration, which could potentially be the source of the variance 
between studies. Chitin and chitosan preparations specified in the literature and several 
novel preparations were analyzed for degree acetylation (DA) using High Performance 
Anion-Exchange Chromatography with Pulsed Amperometric Detection (HPAEC-PAD). 
It was found that autoclaving and sonication processing steps do not have a significant 
influence on degree of acetylation. Chitin and chitosan preparations were used to create a 
dose-response curve of DA compared to cytokine elicitation from THP-1 monocytes, and 
it was found that the initial response was dominated by TNF (similar to previous studies), 
though after 12 hours showed a tip toward the start of an IL-1β-dominated Th17 effector 
response. This study also confirmed that immunostimulatory effects can occur from 
chitin and chitosan particles at or <1µm in size. The results suggest that very small chitin 
particles, which would have long residence times in air, might be implicated in initiating 
allergic or asthmatic processes. 
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CHAPTER 1 
INTRODUCTION 
Chitin is a component of many parasites; hence chitin hydrolases and hydrolase-
like proteins have evolved in plants and animals as a defense mechanism against chitin-
containing organisms. Chitin is also the primary component of insect exoskeletons, the 
encasing material of dust mite droppings, and is found in nearly all fungal spores. These 
substances are among the primary constituents of aerosolized house dust and therefore 
represent a significant source of human chitin exposure on a daily basis.    
One chitin hydrolase, acidic mammalian chitinase (AMCase), has been repeatedly 
linked to asthma and atopy (Zhu et al., 2004; Reese et al., 2007; Sohn et al., 2008; Ober 
et al., 2008). Increased amounts of AMCase expression were found in the 
bronchoalveolar lavage (BAL) fluid of ovalbumin (OVA)-sensitized and OVA-
challenged mice as well as being present in the epithelial cells and alveolar macrophages 
in lung tissues found in human patients suffering from asthma, whereas AMCase was not 
found in healthy non-asthmatic humans (Zhu et al, 2004). Asthma inflammation is driven 
by type 2 helper T-cells (Th2)- immune response to allergenic proteins, mediated by 
interleukin 4, 5, and 13 (IL-4, IL-5, and IL-13) cytokines. In almost all patients, asthma is 
marked by an abnormally high expression of these cytokines in lung tissue. Because 
mammalian chitinases evolved to mount innate immune defenses against chitin-
containing pathogens (Lee and Elias, 2010), chitin itself is likely a pathogen associated 
molecular pattern (Da Silva et al., 2009) capable of triggering asthmatic response.  
Studies regarding the immunogenic reactions to chitin in living models (cell 
culture and murine models) have produced conflicting results. For example, Shibata 
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(1997a, 1997b, 1999, 2001), Strong and Clark (2002), and Da Silva et al. (2008a) all 
found that responses to chitin in mice are size-dependent and tend to elicit Th1-type 
responses.  However, Bueter et al. (2011) found that chitin does not elicit an immune 
response at all; rather chitosan (a deacetylated form of chitin) is responsible for eliciting a 
Th1 response. Yet experiments by Da Silva et al. (2008b) indicated that a Th17 pathway 
may be involved and that the response is independent of phagocytosis, while Shibata’s 
research (Shibata et al. 1997a, 1997b, 2000, 2001) indicates phagocytosis both occurs and 
is required. Reese et al. (2007) found that in mice chitin elicits a Th2 response and 
triggers alternatively activated macrophages, similar to the response seen in asthmatic 
humans.  
The reason for the difference in results is unclear. While chitin has been 
implicated in triggering immune response, chitosan has been utilized for therapeutic 
medical applications, including wound healing and antimicrobial treatments (Dutta, 2004; 
Dai et al., 2009). None of the studies to date have performed quantitative analyses on 
their samples for degree acetylation, the primary difference between chitin and chitosan 
and a key element in the binding of chitinases and chitinase-like proteins. One notable 
difference between the studies is the process by which chitin is prepared for use.   
Methods of preparation used by Shibata et al. (1997a, 1997b, 2000, 2001), Da Silva et al. 
(2008, 2009), and Strong et al. (2002) involve sonication of the chitin particles to obtain 
specific size classifications, including chitin microparticles (1-10µm), chitin fragments 
(40-70µm), or large chitin (70-100µm). Sonication of chitin in water has been shown to 
induce deacetylation (Cardoso et al., 2001) and depolymerization (Baxter et al., 2005). 
Shibata et al. (1997b, 2000, 2001) and Da Silva et al. (2008, 2009) also autoclave their 
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samples. However it has been shown that autoclaving of chitin decreases both molecular 
weight and degree of acetylation, and can increase depolymerization (No et al, 2000, 
2002; Sjoholm et al, 2009). Therefore, differing processing methods may lead to chitin 
preparations with different characteristics that are immunologically significant. The 
degrees to which processing methods used in previous studies affect both particle size 
and the degree of acetylation of chitin have not been well characterized and it is unclear 
how they might have affected study outcomes. Therefore it is still unclear whether chitin 
plays a role in eliciting Th1- or Th2-type immune responses. Conflicting results in the 
literature highlights a need to better characterize these preparations in order to clarify the 
role of chitin in immune and allergic responses. 
The objective of this study is to develop a standardized protocol for chitin 
preparations that controls the degree of acetylation. These preparations will be used in 
human cell culture to elucidate how degree of acetylation influences immune response, 
through cytokine production and the induction of chitinase and chitinase-like protein 
genes.  The results of the study will provide information on the expected type of effector 
t-cell response to airway exposures. The primary hypothesis is that chitin particles with a 
high degree of acetylation will elicit cytokines associated with a Th2-type immune 
response indicative of the induction of an allergic response. 
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CHAPTER 2 
CHITIN, CHITOSAN, AND CHITINASES 
2.1 Chitinases 
Chitinases are chitin hydrolases (enzymes that break down chitin) that are found 
in a variety of life forms. Chitin-containing organisms employ chitinases to control 
growth and molting, while organisms that do not contain chitin use chitinases to 
recognize and defend against chitin-containing pathogens (Gooday, 1999). Chitinase 
family 18 contains the largest number of glycohydrolases, and include chitinases from 
eukaryotes (including mammals), prokaryotes, and viruses (Bussink, 2007).  These 
glycohydrolases contain a 150-residue conserved core that existed prior to the 
prokaryotic/eukaryotic split, with only minor modifications occurring since (Robertus 
and Monzingo, 1999), indicating the important evolutionary role for chitinases.  
There are two primary categories into which chitinases can be grouped: true 
chitinases (AMCase and chitotriosidase) or chitinase-like proteins (YKL-40, Ym1, etc.). 
The functional difference between the two is that true chitinases have a C-terminal chitin 
binding domain and an N-terminal catalytic core domain conferring hydrolytic enzymatic 
activity, whereas chitinase-like proteins have no catalytic domain but can bind to chitin 
(Renkema et al, 1997). It is also important to note that although	   similar	   in	   many	  respects,	  the	  tissue-­‐specific	  expression	  of	  human	  and	  mouse	  chitotriosidase	  is	  quite	  different.	  Mouse	  chitotriosidase	   is	  most	  expressed	   in	   the	   tongue	  and	  stomach	  and	  not	   in	   other	   tissues,	   whereas	   human	   chitotriosidase	   is	   expressed	   in	   lymph	   node,	  bone	  marrow,	  and	  lung,	  but	  not	  in	  the	  stomach.	  Mouse	  AMCase	  is	  highly	  expressed	  in	   the	   stomach,	   salivary	   glands,	   and	   lung	   of	   mice,	   but	   human	   AMCase	   is	   highly	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expressed	   in	   the	   stomach,	   and	   to	   a	   lesser	   extent	   in	   the	   lung.	   Human	   alveolar	  macrophages	   express	   chitotriosidase,	   which	   is	   not	   found	   to	   occur	   in	  mouse	   lung.	  Instead,	  the	  mouse	  alveolar	  macrophages	  express	  AMCase.	  (Boot	  et	  al.,	  2005)	  
All chitinases rely on the presence of the carbonyl oxygen located on the acetyl 
group to initiate hydrolysis (Tews and Terwisscha, 1997; van Aalten et al., 2001), 
indicating that chitinase upregulation is related to the presence of chitin rather than 
chitosan. AMCase, chitotriosidase and chitinase-like proteins have been implicated in 
inflammatory response, atopy, and pathogenesis of human diseases. Their presence 
strongly suggests a link between pulmonary chitin exposure and disease.  
2.1.1 AMCase 
AMCase has been repeatedly linked to asthma and the Th2-type airway 
inflammatory response that causes tissue inflammation and hyperreactivity. In murine 
models, AMCase expression was induced in the presence of IL-13 by Th2-polarized 
cells, while Th1-polarized cells were unable to induce AMCase.  Upon administration of 
anti-AMCase sera, Th2 inflammation decreased in a dose-dependent manner, but did not 
have any effect on mRNA levels of IL-4, IL-5, and IL-13. Increased AMCase expression 
was found in the bronchoalveolar lavage fluid (BAL) of OVA-sensitized and antigen-
challenged mice as well as being present in the epithelial cells and alveolar macrophages 
in lung tissues found in human patients suffering from asthma, while AMCase was absent 
in healthy non-asthmatic humans (Zhu et al., 2004).  
The mouse genes for AMCase and Ym1 (chitinase 3-like-3, corresponding to 
chitinase-3-like-1 in humans) were found to be up-regulated during Schistosoma mansoni 
infection in both wild type mice and Th2-polarized mice (Sandler et al., 2003). The 
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induction of Ym1 is a marker for alternatively activated macrophages and is dependent 
on IL-4 in vivo (Gordon et al., 2002). Ym1 and Ym2 have been found to be induced 
during Th2-type allergic inflammation in mice and are regulated by CD4+ T cells, IL-4 
and IL-13 signaling via the IL-4Rα subunit (Webb et al., 2001) 
 Lung tissue in mice challenged by helminth infection showed that AMCase, Ym1 
and Ym2 were dependent upon induction of STAT-6 (Reese et al., 2007). Zimmerman et 
al., 2004 also found that in OVA-sensitized mice, the genes for AMCase and Ym1 were 
induced within 18h of the first allergen challenge and were STAT-6-dependent. Because 
STAT-6 is required for IL-4 and IL-13 signaling, these results indicate that chitin may be 
a trigger for infiltration of IL-4- and IL-13-producing cells.  
AMCase is found to be up-regulated in inflammatory cells in the nasal mucosa 
associated with allergic rhinitis. Expression of AMCase was also increased in persons 
who suffered from chronic sinusitis, an inflammation of the paranasal sinuses (Cho et al, 
2010). These results suggest that chitin hydrolases may have evolutionarily developed as 
a defense mechanism against airborne fungal pathogens.  
2.1.2 Chitotriosidase 
Chitotriosidase, a true chitinase primarily expressed in the lung in humans, has 
various associations with disease, including Gaucher’s disease, malaria, atherosclerosis, 
asthma, multiple sclerosis, and was found to be elevated in the lungs of smokers (Barone 
et al., 2007; Lee et al., 2007; Seibold et al., 2008). Chitotriosidase is expressed by lung 
macrophages and also in peripheral serum and plasma by activated monocyte-derived 
human macrophages (Barone et al., 2007). Chitotriosidase has also been linked to asthma 
and atopy—Lee et al. (2007) found that subjects with Asian ancestry were more likely to 
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be atopic if chitotriosidase is expressed, and Wu et al. (2010) found that high fungal 
exposures (via aerosolized household dust) along with a single nucleotide polymorphism 
in the CHIT1 intron were associated with severe asthma exacerbations.  
2.1.3 YKL-40 
 YKL-40 is a chitinase-like protein in humans also known as human cartilage 
glycoprotein 39 (HCgp-39) or chitinase 3-like-1 (CHI3L1). It is found in increased 
quantities in the circulation and lungs of some subpopulations of patients with asthma, 
and can correlate with the severity of symptoms and degree of sub-epithelial basement 
membrane thickening (Chupp et al., 2002).  
In a cohort of Korean children, variations in two SNPs within the CHI3L1 gene 
were strongly associated with atopy, increased circulating YKL-40 levels, and increased 
IgE levels, but were unable to be correlated with asthma (Sohn et al., 2008).  
Contrastingly, Ober et al., (2008) found that within a population of European descent, 
CHI3L1 may be an asthma susceptibility locus, as a promoter within the gene was 
significantly associated with serum YKL-40 levels, asthma, and bronchial 
hyperresponsiveness. In murine models, chitinase 3-like-3 (Ym1 in mice), Ym2, 
AMCase, Fizz1 proteins (found in inflammatory zone 1, a marker for alternatively 
activated macrophages) in BAL were found to be increased in OVA-challenged mice as 
compared to a control group, and the same proteins were increased in the lung tissue of 
murine asthma models. Upon treatment with N-acetylcysteine (NAC), expression of Ym1 
and Ym2 were inhibited, indicating that chitinases can serve as oxidative stress proteins, 
and are involved in the pathogenesis of asthma (Zhang et al., 2009).  
2.2 Chitin 
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Found widely in nature, chitin is a nitrogenous cellulose-like polysaccharide 
composed of repeating β(1à4)-linked N-acetyl-D-glucosamine units. As one of the most 
abundant natural polysaccharides, it is found in substances including crustacean shells, 
helminth eggs, insect exoskeletons, dust mite droppings, and in the cell walls of fungi 
(Nathan et al., 2009; Van Dyken et al., 2011). Chitin is insoluble in water and other 
organic solvents, though it begins to show signs of solubility as it approaches 40% 
deacetylation, at which point it is generally referred to as chitosan (Sorlier, 2001; Dutta, 
2004; Rinaudo, 2006), though some disagreement exists. The changeover from chitin to 
chitosan has been cited at 70-100% deacetylated (Aiba, 1992) or at 50% (Chatelet et al., 
2001). Chitin is found naturally in three different crystallographic forms, known as α-
chitin, β-chitin, and γ-chitin. The forms differ in the organization and polarity of their 
polysaccharide chains within sheets, the interaction of which beget distinct 
crystallographic traits. The α- form of chitin is found abundantly, whereas β-chitin is 
found primarily in squid pens, pogonophoran tubes, and the spines excreted by certain 
diatoms (Rinaudo, 2006).  
In nature, chitin acetylation is typically around 90% with a nitrogen content of 
approximately 7% (Meyers, 1995). Source material, purification techniques, and 
processing methodology contribute to differing degrees of acetylation, polymer structure, 
and nitrogen content in the final usable product (Meyers, 1995; Percot, 2003; Brine and 
Austin, 1981) 
2.2.1 Source Material 
Commercial chitin from crustacean sources is typically derived from crab, shrimp 
or lobster. Different sources contain differing amounts of crude protein, crude fat, ash, 
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calcium, and magnesium as impurities, which greatly influence the purification process 
that must be used (Percot, 2003; Meyers, 1995).  Brine and Austin (1981) reported chitin 
content between different crab species ranged from 14.8% to 27.6%, while average 
acetylation and molecular weight did differ, but depended more on purification technique 
than source.  
Nitrogen content in chitin varies by species, which is subsequently a relic of the 
purification method required for extraction. The theoretical value for nitrogen content in 
pure chitin is 6.89% by mass—higher values indicate deacetylation (N% of up to 8.69) or 
remaining protein in the sample, while lower values are indicative of deamination (by 
hydrolysis) or a contamination of the sample (Rutherford and Austin, 1978). 
2.2.2 Purification Techniques for Source Material 
The purpose of purification is to go from crustacean source material to pure 
chitin. This involves deproteinization, demineralization, and optional decolorization. 
Typically deproteinization occurs from a treatment of ground shell material with 1-10% 
NaOH at elevated temperature (65-100°C) to dissolve the protein, though dilute KOH 
solution can be used depending on the species of source material (No and Meyers, 1995). 
Demineralization serves to dissolve any calcium carbonate in the source material. This is 
conventionally done over a short time (1-3 hours) using a dilute HCl solution at room 
temperature, though dilute acetic acid can also be used (Brine and Austin, 1981). 
Decolorization can be achieved by a variety of techniques, most of which involve 
acetone, chloroform, and/or ethanol (No and Meyers, 1995). 
2.2.3 Processing Methodology Used in Experiments 
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Brine and Austin (1981) found that there is a parallel relationship between the 
degree of depolymerization and the degree of deacetylation, and that preparation method 
strongly influences both values. Other techniques used for sterilization, to induce 
solubility, or to reduce particle size can also affect the chemical and physical properties 
of chitin through deacetylation, depolymerization, or change in crystal structure (Brine 
and Austin, 1981).  
2.2.3.1 Autoclaving 
Chitin is sensitive to heat and begins to denture at temperatures as low as 50°C 
(Muzzarelli, 2005). Autoclaved chitin in 45% NaOH solution can decrease degrees of 
acetylation (DA) to between 17.1±0.1 % after 10 minutes and 9.6±0.1% after 30 minutes. 
At 50% NaOH, 30 minutes of autoclaving results in a DA of 8.2±2.9%. It should be 
noted that commercial chitosan averages a DA of 12.4±0.1% (No et al., 2000).  No et al. 
(2002) found that autoclaving chitosan (deactylated chitin) with 1% acetic acid caused 
depolymerization; molecular weight decreased by 51% after 15 minutes and 61% after 60 
minutes. Sjoholm et al. (2009) determined that autoclaving chitosan in the presence of 
strong NaOH causes both depolymerization and even further deacetylation (from 80% to 
98% deacetylation over 30 minutes). Taken together, these results indicate that 
autoclaving can deacetylate and depolymerize chitin. 
2.2.3.2 Sonication 
Sonication used to decrease particle size has physical effects on the properties of 
chitin, as well. Sonication of chitin in water caused aggregation of chitin particles, 
changes in x-ray diffraction patterns (likely due to the size reduction of crystals rather 
than structural changes), grain-like surface protrusions that increase surface area, and 
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activation of chitin for deacetylation reactions (Cardoso et al., 2001). Sonication of 3g 
chitin/100mL of chilled water over 180 minutes was sufficient to show a time-dependent 
creation of oligosaccharides, with peaks of formation at 60 minutes and a significant 
increase at 120 minutes (Takahashi et al., 1994). Machova et al. (1999) showed that 
sonication was able to significantly depolymerize a chitin-glucan complex found in 
Aspergillus niger cell walls, indicating that sonication causes changes on the molecular 
level. 
2.2.3.3 Acid/base treatment 
Acids readily hydrolyze chitin, and concentrated acids can react with chitin to 
form colloidal chitin (a suspension of nanoparticles) (Rupley, 1964). Concentrated HCl 
reacts with β-chitin to decrystalize its structure and completely convert it to α-chitin 
(Saito et al., 1997). Concentrated HCl also depolymerizes chitin though hydrolysis, 
during which the glycosidic linkage is broken, causing both lower molecular weight and 
decrease in acetylation (Brine and Austin, 1981; BeMiller and Whistler, 1962). Prolonged 
time in even dilute HCl solution can also cause depolymerization (Hirano, 1982).  
Concentrated NaOH reacts with chitin to deacetylate it up to 96% after four hours 
at 110°C (Mima et al., 1983), though 78% deacetylation occurred in only 2 hours. In an 
oxygenated environment, exposure to concentrated NaOH can result in both 
deacetylation and depolymerization (Sannan et al., 1976), though in dilute alkali solutions 
it remains relatively stable (Varum et al., 2004).  
3. Chitosan 
 Deacetylated chitin is known as chitosan (less than 40% degree acetylation, 
though fungal chitosans are often in the 10% DA range (Aranaz et al., 2009), and has 
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reactive amino and hydroxyl groups. The free amine is one of the primary causes for the 
solubility of chitosan, another key difference between chitin and chitosan (Aranaz et al., 
2009). The cationic charge responsible for the solubility of chitosan in mild acid solution 
is also responsible for its antimicrobial properties, as the charged amino group is able to 
bind to bacterial membranes and affect nutrient transport to the bacterial cell (Rabea et 
al., 2003). It has also been established that the degree of cell adhesion is directly 
proportional to the degree of acetylation (Mao et al., 2004), further illustrating the 
importance of acetylation. Nitrogen content is generally greater than 7% of the total 
structure because of the lack of acetyl groups.  
Chitosan solutions are extremely sensitive to aging, primarily due to 
depolymerization, aggregate formation, and microbial degredation (Zhao, 2010). It is a 
natural, biodegradable, non-toxic polymer that binds to mammalian and microbial cells, 
and is currently being researched for medical applications (Dutta, 2004). Mao et al. 
(2010) reference chitosan as being used as nonviral carriers for plasmids and drugs, and 
chitosan nanoparticles have been found to protect drugs from enzymatic degradation and 
enhance intestinal absorption (Thanou et al., 2000). Chitosan has been used in burn 
wound dressings to prevent infection and systemic sepsis, and it has been proven to have 
antimicrobial properties (Dai, 2009). Chitosan has also been employed in sutureless 
tissue fixation because it has proven to be biocompatible (Lauto, 2009).  
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CHAPTER 3 
PREVIOUS STUDIES 
3.1 Findings  
3.1.1 Th1-type Response 
Shibata et al. (1997a) found that chitin microparticles (CMP, particle size 1-
10µm) administered intravenously both primed alveolar macrophages and stimulated 
reactive oxygen species (ROI) in SCID and C57BL/6 mouse models. Soluble 
chitin/chitosan oligosaccharides administered similarly did not prime the alveolar 
macrophages. Decreased priming resulted from CMP administered to C57BL/6 mice co-
administered with monoclonal antibodies (mAb) to either IFN-ϒ or NK1.1 (natural killer 
cells). Spleen cells from C57BL/6 or SCID mice exposed to CMP expressed IFN-ϒ, 
whereas cells administered mAb to NK1.1 and CMP resulted in inhibited IFN-ϒ 
production. Cells exposed to chitosan or phagoytosable latex beads produced no IFN-ϒ. 
These results indicate that macrophage priming is, in part, a result of the production of 
endogenous IFN-ϒ by NK1.1+CD4+ cells, which is up-regulated by IL-12 and TNF-α. 
Because the activation also occurred in SCID mice which lack functional T and B cells, 
the priming is a result of innate immune response.  
 Shibata et al. (1997b) explored the mechanism responsible for CMP-induced 
immune response. Splenic macrophage cultures obtained from BALB/c mice were 
administered combinations of soluble mannan, CMP, phagocytosable beads coated with 
either chitin, mannan, or laminarin, or non-phagocytosable agarose beads cross-linked 
with either mannan or N-acetyl-D-glucosamine, or cytochalasin D (an inhibitor of 
phagocytosis). Soluble mannan inhibited the interaction between macrophages and CMP, 
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but does not inhibit IL-12-medited IFN-ϒ production. The non-phagocytosable beads 
elicited no IFN-ϒ whereas the phagocytosable beads coated in carbohydrate did. These 
results indicate that IFN-ϒ/IL-12 production induced by CMP is reliant upon the 
mannose receptor-mediated phagocytosis.  
 Using both C57BL/6 and BALB/c murine models and splenic culture, Shibata et 
al. (1998) found that IL-10 downregulates chitin, BCG and LPS-induced IFN-ϒ 
production, but it remained unclear as to which part of the innate response induced by 
chitin was inhibited by IL-10 though the inhibition is, in part, derived by NK cells and 
macrophages.  
 Shibata et al. (2000) used ragweed-sensitized spleen cells and ragweed-sensitized 
BALB/c and C67BL/6 mice to explore the effects of orally-administered CMP on the 
regulation of Th2 immune response. When CMP were applied to ragweed-sensitized 
spleen cells, IFN-ϒ and IL-10 were secreted, but there was no IL-4 or IL-5 (indicating 
CMP induce a Th1-type response rather than an allergic Th2-type). Chitin microparticles 
and neutralizing Abs to IL-10 or IFN-ϒ were administered and an enhanced IL-4 and IL-
5 response was observed, indicating that IFN-ϒ (later determined to be from NK cells) 
and IL-10 are at least partly responsible for inhibiting the Th2 response to chitin. 
Prophylactic oral administration of CMP to ragweed-sensitized mice led to reduced 
serum IgE, reduced ragweed-specific IgE and increased ragweed-specific IgG2a, which 
indicates isotype switching of B cells. BAL cells showed reduced eosinophil and 
lymphocyte recruitment to the lung and no IL-4 or IFN-ϒ.  
Shibata et al. (2001) then explored the Th1 adjuvant capabilities of CMP. In 
splenic macrophage cultures of WT mice immunized with MBP-59 (a mycobacterium 
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protein), subsequent exposure to MBP-59 induced a Th2 response (IL-4, IL-5, IL-10 and 
no IFN-ϒ) whereas exposure to MBP-59 and CMP showed a reduced Th2 response and 
increased IFN-ϒ production, indicating that CMP down-regulates Th2-type responses 
and up-regulates Th1-type responses. In the WT murine model, exposure to MBP-59 and 
CMP significantly reduced levels of IgG1 and IgE. Administration of MBP-59 alone 
increased total IgE and MBP-59-specific IgG1. In an IL-10 knockout mouse, exposure to 
MBP-59 induced a stronger Th2 response as compared to the WT with enhancement of 
total serum IgE, MBP-59-specific IgE, and increased IgG1. The administration of MBP-
59 and CMP elicited higher IFN-ϒ, reduced IL-4 and IL-5 and IgG2a, indicating B-cell 
isotype switch. These results indicate that endogenous IL-10 down-regulates the IL-4-
dependent IgG1 and IgE production, in addition to the IFN-ϒ-dependent production 
IgG2a. 
In an effort to determine whether chitin could act as a Th1 adjuvant without 
eliciting a Th2-type response, Nishyama et al. (2006) from the Shibata lab administered 
CMP to RAW264.7 macrophage-like cells and found that there was minimal IL-10 
produced and a large TNF-α response. The mitogen-activated protein kinase (MAPK) 
pathway is phosphorylated upon phagocytosis of CMP, and stimulated cells to also 
express COX-2 protein and PGE2. It was also found that there was no direct relationship 
between the inhibition of COX-2 (regulated by the MAPK pathway) and the production 
of TNF-α. Nishyama et al. (2008), using RAW264.7 cells and cellular proteins from the 
RAW264.7 cells associated with exposure to CMP found that depletion of cholesterol 
from the plasma membrane results in minimal alteration of recognition and phagocytosis 
of CMP, as there are different membrane structure requirements for binding and 
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phagocytosis than MAPK activation, cytokine production and PGE2 production. MAPK 
and PGE2 activation indicates a Th1 response, and although also typically associated with 
IL-10 production, this study failed to find any IL-10 production, in contrast to their 
earlier findings (Shibata et al., 1998). 
3.1.2 Th2-type response 
In investigating host responses to allergic and parasitic challenge, Reese et al. 
(2007) found that intranasally-administered chitin in mice caused recruitment of 
eosinophils and basophils to lung tissue, and as demonstrated by intraperitoneal (i.p.) 
injection of chitin, the response was not only limited to the lung. Chitin pre-treated with 
active AMCase and intranasally administered to mice led to loss of cell recruitment in the 
lung tissues. Mice overexpressing AMCase had attenuated inflammatory responses, 
indicating that chitin elicits infiltration of lung tissue by IL-4 competent cells, and 
AMCase halts this activity. Although AMCase is dependent on the Stat-6 and Rag 
pathways, eosinophil recruitment by chitin is not, indicating that the immune response to 
chitin occurs very early. Chitin exposure also causes macrophages to produce eosinophil 
chemoattractant, though chitin ceases to do so if pretreated with AMCase. Basophil and 
eosinophil recruitment by chitin exposure was also attenuated in mice with the 
macrophage-produced chemoattractant leukotriene B4 receptor (BLT-1) knocked out. 
Further experiments revealed that exposure to chitin elicits accumulation of arginase I-
positive macrophages, and that inflammatory macrophages did not acquire arginase I 
expression until later in the response. This indicates that chitin may be a PAMP 
recognized in tissues and implicated in inducing early innate immune responses.  
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Noticing disparities between study results regarding immune response, Kogiso et 
al. (2011) from the Shibata lab investigated the immune response of mice that were given 
i.p. injections of latex beads of various sizes coated in various carbohydrates and 
compared them to their CMP and chitosan microparticles. They found that large, non-
phagocytosable beads (LCB, chitin-coated beads >40µm, analogous to the material used 
by Reese et al., 2007 but differing in processing methodology) induce local eosinophilia 
regardless of carbohydrate composition. They then found that CMP and LCB do not 
significantly influence levels of CHI3L1 nor do they induce IL-10. It was further found 
that CMP actually reduce IL-10 in the presence of inflammatory conditions. In 
RAW265.7 macrophage cell culture, CMP elicited an M1 phenotype (classically 
activated macrophages) whereas LCB did not, and neither elicited arginase I. This differs 
from the in vivo result in which CMP elicited slight ArgIlow (indicating TLR-dependent, 
STAT6-independent) and LCB and Sephadex (uncoated) beads had greater expression of 
ArgIhigh, independent of CRTH2 (receptor for PGD2, responsible for recruitment of Th2 
cells). Taken together, these results indicate that large non-phagocytosable beads, 
regardless of carbohydrate coating, will result in an innate response with alternatively 
activated macrophages.  
3.1.3 Other Responses 
Da Silva et al. (2008) suspected that immune responses to chitin were size 
dependent and used big chitin (70-100µm) and intermediate chitin fragments (40-70µm) 
first on macrophages derived from either peritoneal or bone marrow and found that the 
big chitin had no effect on IL-17 or IL-17AR expression. The fragments, however, 
stimulated IL-17, IL-17AR mRNA and protein expression, IL-12/23p40, IL-23, and 
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TNF-α. Using macrophage cultures from a variety of knockout mice (TLR-2, TLR-4, 
MyD88, IL-17), it was found that chitin fragments stimulate macrophages via a MyD88-
dependent pathway that involves TLR-2 but not TLR-4, and through mechanisms that are 
IL-17-dependent and independent. WT mice given intermediate chitin fragments 
intranasally had acute inflammation and accumulation of IL-12 that are induced by a 
pathway dependent on MyD88, TLR-2 and IL-17. Rag2-/- mice administered intranasal 
chitin fragments produced IL-17, indicating that the response to chitin is innate. Taken 
together, these results imply that chitin is a size-dependent pathogen associated molecular 
pattern (PAMP) that activates TLR-2 and MyD88. The inflammatory response is initially 
neutrophilic and becomes eosinophil-dominated over time. 
Using peritoneal macrophages derived from C57BL/6 mice, Da Silva et al. (2009) 
found that the size of the particle greatly influenced the response of macrophages, as 
large chitin and chitin oligomers had no effect, intermediate chitin (40-70µm) stimulated 
TNF-α through TLR-2-, NFκB- and dectin-1-dependent, phagocytosis-independent 
mechanisms. Small chitin (<40µm, primarily 2-10µm) stimulated TNF-α primarily via 
Syk and dectin-1 (and to some extend the mannose receptor), but unlike intermediate 
chitin, also stimulated IL-10 production. These results indicate that size-dependent 
elicitation of inflammation may be mimicking the response to parasite/pathogen 
elimination, with intermediate and small chitin serving as a PAMP to signal the need for 
destruction and elimination. 
Due to the varying outcomes from other groups, Da Silva et al. (2010) explored 
whether chitin could be an adjuvant for a variety of adaptive immune responses. Using 
both in vivo and in vitro models, it was determined that chitin (a PAMP) is an adjuvant 
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for Th1, Th2, and Th17-type responses and antigen-specific IgE induction, mediated by 
TLR-2 and MyD88-dependent pathways. They also found in the presence of OVA- and 
chitin-sensitized mice (in vivo and with CD4+ T cells in the presence of bone marrow 
derived macrophages), the presence of IL-17 downregulates IFN-ϒ and can cause a tip 
toward a Th2-dominant cytokine profile.  
Amidst the various results of previous chitin and chitinase studies, Bueter et al. 
(2011) investigated the effects of chitin and chitosan on the NLRP3 inflammasome, 
which is triggered by fungal pathogens and is responsible for modulating the release of 
IL-1β, IL-18, and IL-33. The study was conducted on bone marrow macrophages in 
culture and found that, contrary to the previous studies, chitosan and chitosan-coated 
beads elicited a dose-dependent IL-1β response that was dependent on the NLRP3 
inflammasome, was size dependent (particles <20µm) as well as phagocytosis-dependent. 
Chitin, however, did not elicit any significant IL-1β response nor was it able to inhibit IL-
1β release from exogenous stimuli. This indicates that chitosan exposure leans toward a 
Th1-type response, as IL-18 acts to increase IFN-γ release, which downregulates the Th2 
response, though the presence of IL-1β indicates alternatively-activated macrophages.  
 In an effort to determine how chitin modulates immune response, Wagner et al. 
(2010) found that “small” chitin (20-40 µm), administered intranasally simultaneously 
with OVA attenuated antigen-specific CD4+ cell expansion in the lung, but had no effect 
on Th2-cell polarization. Chitin administered with soluble mannan (which competitively 
binds to the mannose receptor) to cultured CD4+ T-cells had no effect on the inhibitory 
effect of chitin, indicating the effect of chitin is mediated by a different cell type. 
Splenocytes cultured with chitin did not express Fizz1, though Arginase 1 [Arg1, a 
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protein expressed in human and murine asthmatic lung cells (Zimmerman et al., 2003)] 
was expressed at low levels. Chitin upregulated B7-H1, an inhibitory ligand on 
macrophages that binds to PD-1 and blocks the PI3K pathway, which inhibits T-cell 
proliferation. The upregulation was independent of MyD88, TLR2, TLR3, TLR4, and 
STAT6.  
3.2 Chitin Processing Methods 
 Studies conducted to date on the immunological response to chitin have used a 
variety of methods in the preparation of the chitin material without proper 
characterization of the resulting degree of acetylation. Table 1 categorizes studies by 
chitin processing method and resulting immune pathway response. Since no clear 
association is evident, it will be important to replicate some of these preparation methods 
and determine degree of acetylation. 
3.2.1 Sonication Without Autoclave 
Shibata et al. (1997a) used purified (C3641) and practical (C7170) grades of 
chitin preparations from Sigma-Aldrich.  To make chitosan, chitin particles were treated 
with 1 - 2M NaOH at 37°C for 4-6 hours. In the case of C7170 further extraction from 
the crude chitin was performed using concentrated HCl, neutralized with NaOH and the 
extracted chitin was then dried.  The chitin powder was then suspended in saline and 
sonicated at 25% output power in a glass vessel with a Branson sonicator (Sonifier 450; 
Branson Ultrasonics, Danbury, Conn.). Sonication occured for 5 minutes, with a 5-minute 
rest on ice and was repeated 5-10 times. This was followed by light centrifugation (50 x 
G, 10 min). Small particles (1 to 10 µm in diameter) in the supernatant were removed, 
filtered through a 400/2800 stainless steel mesh, and further centrifuged to collect the 
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particles at 1,400 x G for 10 min. One milligram of chitin/chitosan particles (1 to 10 µm) 
contained 2x108 to 3x108 particles. Particle sizes and size distribution were flow 
cytometrically determined by comparing chitin particles to several sizes of standardized 
latex bead (1.1, 10.0,and 47.8 µm in diameter; Polysciences, Warrington, Pa.).   
 In the study by Bueter et al. (2011) chitosan (Primex, 76% deacetylated) was 
deacetylated with NaOH, washed with PBS until the pH was neutralized, at which point 
half of the chitosan was reacetylated with NaHCO3 and 97% acetic anhydride, and 
washed with PBS to reach neutral pH. The chitin and chitosan were then passed through a 
100µm nylon mesh filter basket (BD Falcon) and treated with 0.1M NaOH at 22°C for 30 
minutes, followed by two washes with PBS. The particles were then stored at 4°C in 
PBS. The particles were sonicated at 30% output for 5 minutes and fractioned off using 
filtration. Additional sonication occurred for some portions of the study, in which 
particles were suspended in 200µl PBS (at a concentration of 10 mg/ml) in 1.5ml 
microcentrifuge tubes. Sonication occurred for 5 minutes using a horn sonicator at 20% 
output. Degree of acetylation was performed by first digesting the chitin or chitosan to 
monosaccharides. The DA was determined using epi-UV illumination and a FluorChem 
HD2 digital imaging system, and quantified using ImageJ pre-sonication. 
3.2.2 Sonication With Autoclave 
Shibata et al. (1997b, 2000, 2001), Kogiso et al. (2011) and Nishiyama et al. 
(2006, 2008) prepared chitin particles (1–10 µm diameter) from purified chitin powders 
(Sigma, St. Louis, MO), as described in Shibata et al., 1997. The particles were 
suspended in saline at a concentration of 10–16 mg/ml, autoclaved (121°C 30 min), and 
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stored at 4°C until use. The chitin preparations contained undetectable levels of 
endotoxin (0.03EU/ml), as determined by the Limulus amebocyte lysate assay (Sigma). 
Da Silva et al. (2008, 2009, 2010) used chitin powder (Sigma-Aldrich) that was 
suspended in sterile PBS (LifeTechnologies) and sonicated at 25% output power three 
times for 5 min with a Branson sonicator (Sonifier 450, Branson Ultrasonics). The 
suspension was then filtered with 100, 70, and 40 µm sterile cell strainers (BD 
Biosciences). Following centrifugation (2800 x g, 10 min), chitin pellets of different sizes 
(big chitin 70–100 µm, or chitin fragments 40–70 µm) were suspended in the desired 
volume of sterile PBS and autoclaved for 90 minutes. Afterward, 200µl was run on speed 
vac in a pre-weighed tube. Dry chitin was then weighed and calculations were made in 
terms of powder versus initial volume. Particle sizes and size distribution were evaluated 
by flow cytometry by comparing the chitin to different-sized latex bead controls (0.085, 
11.156, and 42.0 µm in diameter; Polysciences). Endotoxin levels were below the limits 
of detection in a Limulus amebocyte lysate assay (Sigma-Aldrich). All work was 
performed under a cell culture hood (even the sonication) to avoid any contamination. 
3.2.3 Centrifugation or Settling Only 
Strong et al. (2002) prepared CMP from pure chitin (Sigma-Aldrich, Poole, UK) 
by Sonication of a suspension of chitin in sterile, endotoxin-free phosphate-buffered 
saline (PBS). The particles were collected by centrifugation, washed with 20% (v/v) 
ethanol to ensure sterility and washed five times with sterile PBS to remove soluble 
chitin. The suspension of CMP was examined by fluorescence-activated cell sorting 
(FACS) and compared with 1 µm and 20 µm standardized beads (Polysciences, Inc., 
Warrington, PA, USA). Ninety-eight per cent of the particles were smaller than 20 µm 
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and 33% were less than 1 µm in size. Sterility was confirmed by absence of colony-
forming units after plating an aliquot on an agar plate and endotoxin was absent. 
  A chitin microbead preparation (New England Biolabs #S6651S) was utilized in 
the study by Reese et al. (2007). The preparation was diluted in a 1:4 ratio in sterile PBS, 
washed three times, and large aggregates were allowed to settle for 2  min. Suspended 
chitin was collected and diluted 1:4 in PBS. The supernatant, which consisted of a bead 
size 10-70µm at 105 beads/ml, as verified by nylon mesh filtering and microscopy, was 
collected and administered (Reese et al., 2007).  
 Wagner et al. (2010) used purified chitin from crab shells (Sigma-Aldrich 
C9752). The chitin was suspended in PBS at room temperature and allowed to stand for 2 
minutes to settle large particles. The supernatant was collected, centrifuged at 14000 rpm, 
and the pellet was resuspended in PBS, and no LPS contamination was found. The 
suspensions were stored at 4°C. The particle size was assumed to be 20-30 µm.  	  
Table	  1:	  Immune	  Responses	  Associated	  With	  Various	  Chitin	  Treatment 
 
  
Chitin Treatment Th1-type response Th2-type response Other response 
Sonication,  
no autoclaving 
Shibata et al., 1997a  Bueter et al., 2011* 
Sonication, plus 
autoclaving 
Shibata et al., 1997b, 
2000, 2001 
Nishiyama et al., 
2006, 2008 
Da Silva et al., 2010 
Da Silva et al., 
2010 
Da Silva et al. 2006, 
2009, 2010;  
Kogiso et al., 2011 
Centrifugation/ 
settling only 
Strong et al., 2002 Reese et al., 2007 Wagner et al., 2010 
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CHAPTER 4 
METHODOLOGY 
4.1 Objective 
The primary goals were to optimize protocol methods to obtain chitin 
preparations with varying degrees of acetylation and particle size and to then identify the 
influence of degree of acetylation of chitin on cellular response. This was achieved by 
using previously-developed protocols and subsequently quantifying the degree of 
acetylation and particle size of chitin resulting from these methods. This then allowed for 
the development of a protocol that ensures reproducible creation of chitin with small 
particle size and either a high, medium or low degree of acetylation. Since previous 
studies have shown that smaller sized chitin is more immunologically relevant, and it is 
the most relevant to airborne exposure to the lung, my studies will focus on small sized 
chitin particles (1-10µm). To determine which steps may be responsible for the 
drastically differing immunologic responses, High Performance Anion-Exchange 
Chromatography with Pulsed Amperometric Detection (HPAEC-PAD) will be performed 
on sonicated samples before autoclave and at 30 and 90 minutes post-autoclave and after 
various chemical manipulations of degree acetylation. All preparations will be done in 
triplicate.   
4.2 Previous Chitin Preparation Methods 
4.2.1 Shibata Method 
This technique has been used fairly extensively in chitin preparations (Shibata et 
al., 1997a, 1997b, 1999, 2001; Da Silva et al., 2008, 2009; Koller et al., 2011; Kogiso et 
al., 2011, Nishiyama et al., 2006, 2008). Purified chitin from crab shells (Sigma Aldrich 
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C3641) is suspended in 30 ml saline at a concentration of 10 mg/ml in a 50 ml Falcon 
tube. The chitin is then sonicated twice, which includes the glass vessel being chilled, put 
in an ice bath, and sonicated at 25% output (Sonifer 450; Branson Ultrasonics, Danbury, 
CT) for 5 minutes. The preparation is centrifuged (50 x g, 10 minutes), supernatant 
collected, filtered through a 400/2800 stainless steel mesh (or 10µm nylon mesh), and 
further centrifuged (1400 x g, 10 min) to collect the chitin particles. The chitin was then 
suspended in saline at a concentration of 10 mg/ml and autoclaved at 121°C 15 psi for 30 
minutes.  
4.2.2 Da Silva Method 
See Shibata through filtering step. The desired size fraction was autoclaved for 90 
minutes at 121°C, 15 psi. 
4.3 Novel Protocol for Preparation of Pure Chitin and Chitosan 
4.3.1 Particle size fractionation (1-10 µm) 
Purified chitin from shrimp shells (Sigma Aldrich C9752) is suspended in PBS at 
a concentration of 10 mg/ml in a 50mL conical tube (Eppendorf). The tube of chitin is 
placed into an ice bath and undergoes sonication at 20% output (Fisher Scientific Sonic 
Dismembrator) for four periods of five minutes each. The suspension is then centrifuged 
at 50 x g for 10 minutes. The supernatant is collected and sieved through a stainless steel 
#400 mesh and collected in a 15 mL conical tube (BD Falcon). The resulting suspension 
of CMP is then centrifuged at 1400 x g for 10 minutes. The supernatant is removed and 
the remaining pellet is then resuspended in endotoxin-free PBS at the desired 
concentration. The Shibata, fully acetylated chitin, and partially deacetylated chitin 
preparations were dried and reconstituted with PBS to the desired concentration. All 
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chitosan preps were kept wet, centrifuged three times at 1600 x g for 10 minutes with 
excess water removed between centrifugation. The mass was determined, approximated 
that 90% of the mass was water, and reconstituted to the desired concentration.  
4.3.2 Deacetylated Chitin 
Deacetylation was performed by exposing the chitin microparticle sample to 1.0M 
NaOH at the concentration of 6 mg chitin/0.08 ml NaOH at 60°C for four hours, then 
washed with PBS until the sample returned to neutral pH.   
4.3.3 Acetylated Chitin 
To acetylate, 30mg sonicated and dried chitin was suspended in 200µl 1.0M 
sodium bicarbonate (NaHCO3), to which 10 µl of 97% acetic anhydride (C4H6O3) was 
added. This reaction was performed for 20 minutes at 22°C with periodic mixing. The 
chitin was then collected by centrifugation at 1400 x g for 15 minutes, and resuspended in 
fresh sodium bicarbonate and acetic anhydride. The reaction was performed for 20 
minutes at 22°C followed by 10 minutes at 100°C. The preparation was centrifuged to 
collect the chitin particles, which were then washed twice with PBS. Degree of 
acetylation was assessed using HPAEC-PAD conducted by the CCRC.  
4.3.4 Partially-acetylated Chitosan 
Crab chitosan (Sigma) was suspended at 10 mg/mL in 30 mL RO/DI water. The 
size fractionation occurred in the same manner as chitin particles. The chitosan was then 
treated with acetic anhydride using the same protocol used for acetylating chitin, without 
the second acetic anhydride exposure and heating.  
4.3.5 Commercial Chitosan 
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Crab chitosan (Sigma) was suspended at 10 mg/mL in 30 mL RO/DI water. The 
size fractionation occurred in the same manner as chitin particles. The chitosan was not 
treated chemically, and was autoclaved for 30 minutes.  
4.3.6 Purified Chitosan 
Crab chitosan was suspended at 10 mg/mL in 30 mL RO/DI water. The size 
fractionation occurred in the same manner as chitin particles. The deacetylation 
procedure followed the same protocol of the deacetylation of chitin particles where the 
sample was exposed to 1.0M NaOH at 60°C for four hours, then washed with PBS.  
4.4 Determination of Degree Acetylation of Samples 
 Many techniques exist for determination of degree acetylation of chitin and 
chitosan. Of interest are nuclear magnetic resonance (NMR) techniques and mass 
spectrometry, particularly 1H NMR and High Performance Anion-Exchange 
Chromatography with Pulsed Amperometric Detection (HPAEC-PAD). After consulting 
with Dr. Parastoo Azadi of the Complex Carbohydrate Research Center (CCRC) at the 
University of Georgia, the industry standard and leading analytic tool for determining 
degree of acetylation chitin is via HPAEC-PAD. Dried samples (0.5-1.0g) were sent out 
to the CCRC for analysis, and they digested it using a chitinase from T. viridae (C8241, 
Sigma) and chitosanase from S. griseus (C9830, Sigma) to create analyzable monomers, 
and finally it was analyzed using a Dionex ICS3000 system equipped with a gradient 
pump, an electrochemical detector, and an autosampler.   
4.5 Particle Size Determination 
A fluorescence-activated cell sorting (FACS) analysis using Spherotech 
polystyrene beads of known sizes and concentration was run to assess size using a BD 
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LSR II flow cytometer. Spherotech kits used were NPPS-4k (sizes 0.1-0.3µm, 1.0-1.9µm) 
and PPS-6K (sizes 5.0-5.9µm, 8.0-12.9µm).  
4.6 Endotoxin Screen 
All replicates were tested for the presence of endotoxin using a GenScript 
ToxinSensor™ Single Test gel clot endotoxin screen kit at the sensitivity of 0.03 EU/mL 
used according to manufacturer guidelines. Using Eppendorf BioPur pipette tips, 200µl 
of sample was transferred into each vial, shaken to mix properly, and incubated at 37°C 
in a water bath for 60 ±	   2	  minutes.	   Each	   vial	  was	   then	   inverted	   to	   check	  whether	  gelation	  had	  occurred	  (a	  +ve	  reaction	  indicating	  >0.03	  EU).	   
4.7 Cell Culture Protocol 
4.7.1 THP-1 Cell Line 
 The THP-1 cell line is a human monocytic cell line that expresses pattern 
recognition receptors, including TLRs. THP-1 cells also express YKL-40, chitotriosidase 
(CHIT-1) and chitinase 3-like-1 (CHI3L1) on the cell surface and can actively bind to 
chitin (Vega et al., 2010; Salah et al., 2012). Drago et al. (2010) have reported that 
stimulation with various strains of Lactobacillus elicited measurable Th1- and Th2-type 
cytokine response, including IL-12, IFN-γ, IL-4 and IL-5 while Auwerx (1991) reported 
that THP-1 cells can also secrete IL-1α, IL-1β, and TNF-α.  Additionally, IL-6 and IL-8 
have been reported to be elicited in PMA-stimulated cells (Daigneault et al., 2010). The 
addition of phorbol-12-myristate-13-acetate (PMA) to the THP-1 cells causes the cells to 
cease proliferating and differentiate into macrophages (Auwerx, 1991) and can be used as 
a positive control.  
4.7.2 Maintenance and Storage of Cell Line 
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The THP-1 cell line was obtained from ATCC and stored in liquid nitrogen until 
thawed. As recommended by ATCC, the growth medium used consisted of the 
recommended ATCC formulation of RPMI-1640 medium (Gibco), 10% triple 0.1μm 
filtered fetal bovine serum (JR Scientific). This will hereafter be referred to as complete 
RPMI-1640 growth medium. All cell work was performed under sterile conditions in 
laminar flow.  
Cells were thawed and the contents were transferred using a serological pipette to 
a sterile 15ml Falcon tube containing 6mL complete RPMI-1640 growth medium. The 
tube was centrifuged at 200 x g for 5 minutes until a pellet formed. The supernatant was 
aspirated, and the pellet was resuspended in 6mL fresh complete RPMI growth medium 
and subsequently placed in a sterile 250ml Falcon tissue culture flask with a 0.2μm 
microporous hydrophobic membrane filter. The cells were then incubated at 37°C in 5% 
CO2. After three days, cell viability was assessed using trypan blue stain, and found to be 
approximately 95% viable.  
 Cell concentration was assessed using a hemacytometer and light microscope, and 
once concentrations reached 2-4 x 108 cells/ml, indicating log-phase growth (Freshney, 
1987), the cells were split in a 1:2 ratio. This occurred every 3-4 days.  When splitting, 
cells were aspirated from the Falcon flasks, gently placed into 15ml Falcon tubes, and 
centrifuged at 200 x g for 5 minutes. The supernatant was aspirated and discarded, the 
pellet was resuspended in 9ml of fresh complete RPMI-1640 growth medium pre-
warmed to 37°C, and transferred into Falcon flasks. The flasks were then immediately 
placed back into the incubator.  
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 On the third passage, 18 vials of cells were frozen. At the time of freezing, the 
cells were at a density of 1 x 106 cells/ml. The freezing medium consisted of complete 
RPMI-1640 with 20% glycerol as a cryoprotectant. The cells were transferred to a 15mL 
Falcon tube and centrifuged at 200 x g for 5 minutes. The supernatant was aspirated and 
discarded, and the cells were resuspended in 6 ml of the freezing medium. The cells were 
then aliquoted into 1.2 ml sterile cryovials to a volume of 1.0 ml. The vials were then 
placed in a Mr. Frosty (Nalgene) in an -80°C freezer overnight, and subsequently 
transferred to liquid nitrogen storage.  
4.7.3 Administration of Chitin Preparations and Collection of Supernatant 
 Prior to administration, all preparations were sonicated between 30 seconds to one 
minute at 70% output using a probe that was sanitized using 70% ethanol. Then, 6.5mL 
of the desired microparticle preparation, at a concentration of 1x106 particles/mL, was 
transferred into the wells of a 24-well plate using Eppendorf BioPur pipette tips. An 
equal volume of THP-1 cells at a concentration of 1x106 cells/ml was added to each 
active well and the time point began. PMA was used as a positive control and sterile 
endotoxin-free PBS was used as a vehicle control. The plates were then incubated at 
37°C with 5% CO2. Time points for analysis were 6, 12, 18 and 24 hours for each 
replicate.  
After the time points had been reached, the supernatant was collected using 
Eppendorf BioPur pipette tips and placed into Axygen pyrogen-free 1.6-mL snap-top 
tubes. The tubes were centrifuged at 900 x g for 5 minutes. The supernatant was collected 
into fresh Axygen pyrogen-free tubes using Eppendorf BioPur pipette tips and then 
subsequently frozen. The cell material remaining was treated with Qiagen RNAProtect in 
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accordance with manufacturer guidelines and then frozen. Briefly, 5-10 volumes of RNA 
Protect were added per volume of cells, and then vortexed to resuspend.  
4.8 Analysis  
4.8.1 Cytokines 
To give as robust an analysis as possible, cytokines from both Th1- and Th2-type 
responses will be analyzed. A BD Biosciences cytometric bead assay (CBA) flex set and 
a BD Biosciences flow cytometer (LSR II) was used to analyze the supernatant samples 
for the presence of IFN-γ, TNF, GM-CSF, IL-1β, IL-6, IL-10, IL-12, IL-2, IL-17a, IL-13, 
and IL-4. Serial dilutions of all lyophilized standards were reconstituted using assay 
buffer. The capture beads were vortexed prior to mixing, and were diluted in an 
appropriate amount of capture bead diluent to prepare enough for 97 tests. The 
Phycoerythrin (PE) detection reagent was prepared in a similar way. The assay was 
prepared by adding 50μl	  of	  each	  sample	   to	  a	  12x75	  Falcon	  round-­‐bottomed	  tube	   to	  which	  50μl	  of	   the	  mixed	  capture	  beads	  were	  added.	  The	  tubes	  were	   incubated	   for	  one	  hour	  at	  room	  temperature,	  after	  which	  50μl	  of	  the	  mixed	  PE	  detection	  reagent	  was	   added	   and	   incubated	   for	   an	   additional	   two	  hours.	  Wash	   buffer	  was	   added	   to	  each	  assay	  tube,	  centrifuged	  at	  200	  x	  g,	  washed	  with	  wash	  buffer,	  and	  resuspended	  for	  analysis	  in	  300μl	  wash	  buffer.	   
4.8.2 Morphological Changes 
Since it is thought that chitin induces innate immune responses very early in the 
immune response, exposure of monocytes to chitin could lead to differentiation into 
macrophages. Differentiation of THP-1 cells is quite evident under the microscope. The 
primary visual cue is that the cells transform from being in suspension to being adherent 
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(Schwende et al, 1996). Markers of macrophage polarization (M1 classically-activated or 
M2 alternatively activated) would give further insight as to potential polarization toward 
parasitic pathogen response (Martinez et al., 2009). Macrophage polarization can be 
determined using real-time PCR and several markers: TNF-α and CXCL11 for M1 
macrophages, and CCL18 and CD206 for M2 macrophages.  
4.8.3 Statistical Methods and Data Analysis 
All statistics were performed using StatPlus (AnalystSoft), XLSTAT (Addinsoft) 
and Microsoft Excel 2011 for Mac. To analyze whether autoclaving and sonication had a 
significant effect on degree of acetylation as compared to sonication alone, two-tailed t-
tests were used with a p=0.05. To determine whether source species influenced degree of 
acetylation post-sonication, a two-tailed t-test was used with a p=0.05. To assess 
statistical significance between chitin and chitosan preparations, pairwise comparisons 
were made using Tukey’s test.   
 To analyze flow cytometry data, FCAP Array 3.0 (BD Biosciences) was used to 
create a standard curve and interpolate the presence and concentration of cytokines.  
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CHAPTER 5	  
 
RESULTS 
 
5.1 High Performance Anion Exchange Chromatography with Pulsed 
Amperometric Detection (HPAEC-PAD)  
 
 High Performance Anion Exchange Chromatography with Pulsed Amperometric 
Detection (HPAEC-PAD) was used to quantify the number of moles of both N-acetyl-D-
glucosamine (GlcNAc) and glucosamine (GlcN). As show in Table 4, the acetylated 
samples (A1, A3, A4) had 3.12, 2.20 and 2.88 nMoles of GlcNAc, respectively and 0.00 
nMoles of GlcN, with a degree of acetylation of 100.00%. The Da Silva samples D1, D3 
and D4 remained fairly highly acetylated (degree acetylation between 97.55 and 100.05 
with mean acetylation 98.72 ± 1.26) as seen in Table 5.  Chitin processed using the 
Shibata method (Table 6) yielded an average degree of acetylation of 97.72 ± 0.59. 
Deacetylating chitin resulted in an average degree of acetylation of 89.33 ± 1.20 (Table 
7). The degree of acetylation of two differing sources of chitin (shrimp and crab) was 
compared. The sonicated and otherwise untreated shrimp chitin averaged 96.42 ± 0.43 
acetylated, and the crab chitin subjected to the same treatment averaged 96.51 ± 0.79 
acetylated (Table 8).  
 Samples of chitosan that underwent the partial-acetylation procedure (acetylated 
chitosan 1, 5, and 6) had degrees of acetylation between 79.00% and 95.3% with a mean 
acetylation of 86.00 ± 8.39 (Table 9). Chitosan samples that were sonicated and 
autoclaved for 30 minutes (Commercial Chitosan samples 7, 8, and 9) had a degree 
acetylation of 56.3, 56.2, and 70.6, respectively. The average degree acetylation was 
61.03% ± 8.29 (Table 10). Chitosan samples that were purified (Purified Chitosan 2, 3, 
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and 4) had degrees of acetylation ranging from 9.5 to 20.7, with a mean of 14.97 ± 5.60 
(Table 11). 
 I compared means between the sonicated crab sample and the Shibata preparation 
(which includes sonication and a 30 minute autoclave treatment) with the null hypothesis 
being that there is no difference in degree acetylation between samples that were 
sonicated alone versus samples that were sonicated and then autoclaved. A two-tailed t-
test was used and a p-level of 0.13982 (i.e. p>0.05) was found. For the Da Silva method 
(sonication and a 90 minute autoclave treatment), the p-level was 0.12076 (Table 12).  
Similarly, a two-tailed t-test was used to determine whether there was a significant 
difference in the degree of acetylation between chitin sources and a p-value of 0.89524 
was obtained (Table 12). These results indicate that the null hypothesis cannot be 
rejected, therefore autoclaving does not induce a statistically significant change in degree 
of acetylation, nor does the source from which the chitin is derived. I used a one-way 
analysis of variance (ANOVA) to compare the means of all of the groups of degree 
acetylation with their respective within-group variability, and a p<<0.05 indicates that the 
groups differ significantly in their degree of acetylation (see table 15).  
5.2 Endotoxin Screen 
 Two days after the chitin samples were used in cell culture experiments, all 
samples were tested for the presence of >0.03 EU/mL of endotoxin. All samples were 
stored at 4°C until testing. Sample CC7 was the only sample to test positive for 
endotoxin. All other samples were below 0.03 EU/ml.  
5.3 Size Determination  
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The Spherotech beads were used to gate the flow cytometer on 1.34μm, 5.1μm, 
and 10.1μm. The histogram display indicated that most particles were below 1.34μm	  (see	  Appendix	  A).	   
5.4 Cytokine Bead Array  
 Due to technical difficulties in establishing a well-fit standard curve, standard 
curves had to be fit for each cytokine individually. The data was still somewhat limited 
and several cytokines (IL-4, IL-12p70, IL-13, IFN-ϒ, GMCSF, IL-2, and IL-17a) were 
extrapolated to concentrations well below the standard curve or were not able to be 
calculated. These were omitted from analysis and IL-1β, TNF, IL-10, and IL-6 were used. 
Cytokine profiles had a large variability between preparations and standard curves were 
truncated (see Appendix B), therefore cytokines present at very low concentrations may 
not have been accurately reported.  
The CBA assay indicated that IL-1β was present in the 61% acetylated 
commercial chitosan sample at 6 hours (mean concentration 34.4 pg/mL ± 55.0), 12 
hours (mean concentration 34.4 pg/mL ± 55.0), 18 hours (mean concentration 170.7 
pg/mL ± 84.5) and 24 hours (mean concentration 95.2 pg/mL ± 86.1). IL-1β was also 
present in the 97.7% acetylated Shibata preparations at 12 hours (mean concentration 
16.7 pg/mL ± 12.1), 18 hours (mean concentration 16.9 pg/mL ± 24.7) and 24 hours 
(mean concentration 9.6 pg/mL ± 12.1) as well as the 15% acetylated purified chitosan 
preparations at 18 hours (mean concentration 58.0 pg/mL ± 49.4) and 24 hours (mean 
concentration 62.8 pg/mL ± 70.4) (see Table 13, Figures 3-7). 
TNF was present in all samples at 6 hours, and all samples except partially 
deacetylated chitin (89.5% acetylated) at 12 and 24 hours. At 18 hours, it was again 
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present in all samples except purified chitosan.  At 24 hours, it was present in the Shibata 
prep (mean concentration 47.5 pg/mL ± 34.5) and commercial chitosan (mean 
concentration 69.0 pg/mL ± 71.8) (see Table 14). IL-10 was found only in the Shibata 
method at 12 hours (mean concentration 9.7 pg/mL ± 14.0) (see Table 15). IL-6 was 
present in deacetylated chitin at 6 hours (mean concentration 14.6 pg/mL ± 6.3) and in 
the Shibata method at 24 hours (mean concentration 14.6 pg/mL ± 6.3). This indicates a 
shift from an early TNF-dominated response to an IL-1β response. IL-10 appeared at the 
12-hour time point, after which IL-1β is present at higher concentrations (see Tables 15-
18, Figures 3-7).  
 The degree of acetylation seems to affect cytokine production/presence at later 
time points, particularly for IL-1β. Mid-acetylated chitin/chitosan seems to have the 
greatest IL-1β elicitation at all time-points, and would seem to cause a time-dependent 
Th2-polarizing tip from an initially Th1-polarizing response, as Th17 cytokines (IL-1β 
and IL-6) are present and Th1 cytokines (TNF) become less predominant. The presence 
of TNF at the earliest time point indicates an initial Th1-polarizing response that is either 
reduced or eliminated over time. Because IL-10 inhibits Th1 polarization, the switch 
between the two may be occurring around the 12-hour time point (Figures 3-7; Tables 12-
17).  The presence of endotoxin does not seem to have greatly affected the cytokine 
elicitation within the CC7 sample, and it appears to have much lower concentrations of 
cytokines than both CC8 and CC9 (Figures 10-12). Although endotoxin was present, the 
exact value above 0.03 EU/mL is unknown, however, IFN-γ would have been expected 
as a cytokine elicited in a significant contamination (Shibata et al., 1997a; Duramad et al., 
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2006). Both the vehicle control and positive control were negative for cytokine elicitation 
(Figures 8 and 9).  
5.5 Morphological Changes 
Little to no visual change was observed in cells at the 6-hour time point. At the 12 
and 18-hour time point, cells exposed to acetylated chitin (100% DA), the Shibata 
method (97.7% DA), and commercial chitosan (61.0% DA) appeared slightly granular 
and began to look misshapen, while all others appeared to be mostly hyaline and round. 
Little was observed between 18 and 24-hours. 	  From	  visual	  morphological	  changes,	   it	  would	  appear	   that	   the	  THP-­‐1	  monocytes	  did	  not	  begin	   to	  differentiate	  until	  12-­‐18	  hours.	   	   It	   does	   not	   appear	   that	   the	  monocytes	   fully	   differentiated	   even	   at	   the	   24-­‐hour	  point.	   
 
Table 2: Summary, Degree Acetylation of Chitin Preparations (HPAEC-PAD) 
 Acetylated 
chitin 
Deacetylated 
chitin 
Shibata Da Silva 
% Acetylation 100.00 ± 0 89.72 ± 1.26 97.72 ± 0.59 98.33 ± 1.20 
 
Table 3: Summary, Degree Acetylation of Chitosan Preparations (HPAEC-PAD) 
 Acetylated 
chitosan 
Commercial 
chitosan 
Purified chitosan 
% Acetylation 86.00 ± 8.39 61.03 ± 8.28 14.97 ± 5.60 
 
Table 4: Degree Acetylation of Acetylated Chitin (HPAEC-PAD) 
Sample A1 A3 A4 Average 
GlcN 0.00 0.00 0.00  
GlcNAc 3.12 2.20 2.88  
GlcNAC:GlcN     
°DA 100.00 100.00 100.00 100.00 ± 0 
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Table 5: Degree Acetylation of Da Silva Method(HPAEC-PAD) 
Sample D1 D3 D4 Average 
GlcN 0.09 0.04 0.00  
GlcNAc 3.77 2.47 3.80  
GlcNAC:GlcN 39.78 68.15   
°DA 97.55 98.55 100.05 98.72 ± 1.26 
 
Table 6: Degree Acetylation of Shibata Method (HPAEC-PAD) 
Sample S1 S3 S4 Average 
GlcN 0.07 0.06 0.05  
GlcNAc 3.31 3.10 1.51  
GlcNAC:GlcN 49.83 50.99 32.80  
°DA 98.03 98.08 97.04 97.72 ± 0.59 
 
 
Table 7: Degree Acetylation of Deacetylated Chitin (HPAEC-PAD) 
 
Sample Da1 Da3 Da4 Average 
GlcN 0.21 0.06 0.24  
GlcNAc 1.76 0.60 1.78  
GlcNAC:GlcN 8.56 9.43 7.36  
°DA 89.54 90.41 88.03 89.33 ± 1.20 
 
Table 8: S Degree Acetylation of Sonicated Shrimp and Crab Chitin (HPAEC-PAD) 
Sample Shrimp1 Shrimp2 Crab3 Crab4 
GlcN 0.10 0.15 0.12 0.19 
GlcNAc 2.91 3.76 3.97 4.52 
GlcNAC:GlcN 29.52 24.67 33.12 23.72 
°DA 96.72 96.11 97.07 95.95 
 
Table 9: Degree Acetylation of Acetylated Chitosan (HPAEC-PAD) 
  Acetylated Chitosan1 
Acetylated 
Chitosan 5 
Acetylated 
Chitosan 6 
 
Average 
GlcN 0.12 0.48 0.72  
GlcNAc 2.4 2.47 2.73  
GlcNAC:GlcN 20.4 5.1 3.8  
DA 95.3 83.7 79 86.00 ± 8.39 
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Table 10: Degree Acetylation of Commercial Chitosan (HPAEC-PAD) 
  Commercial Chitosan 7 
Commercial 
Chitosan 8 
Commercial 
Chitosan 9 
Average 
GlcN 1.11 1.07 0.84  
GlcNAc 1.43 1.37 2  
GlcNAC:GlcN 1.3 1.3 2.4 
 
DA 56.3 56.2 70.6 61.03 ± 8.28 
 
Table 11: Degree Acetylation of Purified Chitosan (HPAEC-PAD) 
  Purified Chitosan 2 
Purified 
Chitosan 3 
Purified 
Chitosan 4  
 
Average 
GlcN 1.22 1.7 2.05  
GlcNAc 0.32 0.18 0.35  
GlcNAC:GlcN 0.3 0.1 0.2 
 
DA 20.7 9.5 14.7 14.97 ± 5.60 
 
Table 12: Sonicated Autoclaved Preparations and Species Statistics 
  
90 Minute 
Autoclave 
Compared to 
Sonication Alone 
30 90 Minute 
Autoclave 
Compared to 
Sonication Alone 
 
 
Crab Chitin Compared to 
Shrimp Chitin 
Degrees 
Freedom 3 3 
 
2 
Test Statistic 2.14956 1.99633 0.14898 
p-level 0.12076 0.13982 0.89524 
t critical 
value (5%) 3.18245 3.18245 4.30265 
Pooled 
variance 1.26461 0.43842 0.40663 
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Table 13: One-Way Analysis of Variance of Degree Acetylation Among Preparations 
 
Summary             
Groups Sample size Sum Mean Variance     
Acetylated 3 300. 100. 0.E+0     
Shibata 3 293.15 97.71667 0.34403     
Deacetyl 3 267.98 89.32667 1.45023     
CC 3 183.1 61.03333 68.64333     
PC 3 44.9 14.96667 31.41333     
              
ANOVA             
Source of 
Variation SS df MS F p-level F crit 
Between 
Groups 15,350.33 4 3,837.58 188.39 <<0.05 4.81564 
Within 
Groups 203.70 10 20.37       
 
Table 14: Cytokine Bead Array Assay Limits of Detection  
Cytokine Lower Limit of Detection 
(pg/mL) 
Upper Limit of Detection 
(pg/mL) 
IL-1β 5.30 301.07 
TNF 55.06 294.90 
IL-10 3.22 295.62 
IL-6 21.91 289.78 
IL-17a  104.46 242.43 
IL-4 66.89 283.05 
IL-2 5.50 285.08 
IL-13 17.41 314.76 
IL-12p70 5.82 310.30 IFN-­‐ϒ 47.19 303.37 
GM-CSF 8.89 269.48 	  
Table 15: Mean (and standard deviation) cytokine concentrations of IL-1β (pg/mL) by 
mean degree of acetylation of various chitin/chitosan preparations 	  
 100% 
acetylated  
97.7% 
acetylated 
89.3% 
acetylated 
61% 
acetylated 
15% 
acetylated 
6 hour 2.6 (0.00) 2.6 (0.00) 2.6 (0.00) 34.4 (54.95) 2.6 (0.00) 
12 hour 2.6 (0.00) 16.7 (12.1) 2.6 (0.00) 34.4 (55.0) 2.6 (0.00) 
18 hour 2.6 (0.00) 16.9 (24.7) 2.65 (0.00) 170.7 (84.5) 58.0 (49.4) 
24 hour 2.6 (0.00) 9.6 (12.1) 9.6 (12.2) 95.2 (86.1) 62.8 (70.4) 
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Table 16: Mean (and standard deviation) cytokine concentrations of TNF (pg/mL) by 
mean degree of acetylation of various chitin/chitosan preparations 	  
 100% 
acetylated  
97.7% 
acetylated 
89.3% 
acetylated 
61% 
acetylated 
15% 
acetylated 
6 hour 80.2 (91.2) 152.1 (215.8) 82.0 (91.2) 156.5 (119.8) 67.4 (34.5) 
12 hour 58.9 (52.9) 125.8 (122.2) 27.5 (0.0) 120.1 (56.8) 47.5 (34.5) 
18 hour 47.5 (34.5) 78.0 (46.6) 47.5 (34.5) 47.5 (34.5) 27.5 (0.0) 
24 hour 327.5 (0.0) 47.5 (34.5) 27.5 (0.0) 69.0 (71.8) 27.5 (0.0) 
 
Table 17: Mean (and standard deviation) cytokine concentrations of IL-10 (pg/mL) by 
mean degree of acetylation of various chitin/chitosan preparations 	  
 100% 
acetylated  
97.7% 
acetylated 
89.3% 
acetylated 
61% 
acetylated 
15% 
acetylated 
6 hour 1.6 (0.00) 1.6 (0.00) 1.6 (0.00) 1.6 (0.00) 1.6 (0.00) 
12 hour 1.6 (0.00) 9.7 (14.0) 1.6 (0.00) 1.6 (0.00) 1.6 (0.00) 
18 hour 1.6 (0.00) 1.6 (0.00) 1.6 (0.00) 1.6 (0.00) 1.6 (0.00) 
24 hour 1.6 (0.00) 1.6 (0.00) 1.6 (0.00) 1.6 (0.00) 1.6 (0.00) 
 
 
Table 18: Mean (and standard deviation) cytokine concentrations of IL-6 (pg/mL) by 
mean degree of acetylation of various chitin/chitosan preparations 	  
 100% 
acetylated  
97.7% 
acetylated 
89.3% 
acetylated 
61% 
acetylated 
15% 
acetylated 
6 hour 16.1 (89) 11.0 (0.00) 14.6 (6.3) 11.0 (0.00) 11.0 (0.00) 
12 hour 11.0 (0.00) 11.0 (0.00) 11.0 (0.00) 11.0 (0.00) 11.0 (0.00) 
18 hour 11.0 (0.00) 11.0 (0.00) 11.0 (0.00) 11.0 (0.00) 11.0 (0.00) 
24 hour 11.0 (0.00) 14.6 (6.3) 11.0 (0.00) 11.0 (0.00) 11.0 (0.00) 
 
 
Figure 1: Average Degree Acetylation of Chitin and Chitosan Microparticle 
Preparations Analyzed Using HPAEC-PAD ± Standard Error, Bars With Different 
Superscripts Are Significantly Different (Tukey’s Test, p<0.05) 
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Figure 2: Degree Acetylation of Applied Chitin and Chitosan Microparticle 
Preparations Analyzed Using HPAEC-PAD 	  
  
Figure 3: Cytokine Elicitation of THP-1 Cells by Fully Acetylated Chitin (DA 100%) 
Over 24 Hours Analyzed Using a Cytokine Bead Array and Flow Cytometry, With 
Standard Error Bars 
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Figure 4: Cytokine Elicitation of THP-1 Cells by Chitin Prepared Using the Shibata 
Method (DA 97.7%) Over 24 Hours Analyzed Using a Cytokine Bead Array and 
Flow Cytometry, With Standard Error Bars 
   
 
Figure 5: Cytokine Elicitation of THP-1 Cells by Partially Deacetylated Chitin (DA 
89.3%) Over 24 Hours Analyzed Using a Cytokine Bead Array and Flow 
Cytometry, With Standard Error Bars 
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Figure 6: Cytokine Elicitation of THP-1 Cells by Commercial Chitosan (DA 61%) 
Over 24 Hours Analyzed Using a Cytokine Bead Array and Flow Cytometry, With 
Standard Error Bars 	  
	  
Figure	  7:	  Cytokine	  Elicitation	  of	  THP-­‐1	  Cells	  by	  Purified	  Chitosan	  (DA	  15%)	  
Over	  24	  Hours	  Analyzed	  Using	  a	  Cytokine	  Bead	  Array	  and	  Flow	  Cytometry	  
With	  Standard	  Error	  Bars	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Figure	  8:	  Cytokine	  Elicitation	  of	  THP-­‐1	  Cells	  by	  Vehicle	  Control	  (Phosphate	  
Buffered	  Saline)	  Over	  24	  Hours	  Analyzed	  Using	  a	  Cytokine	  Bead	  Array	  and	  
Flow	  Cytometry	  
 
  
Figure	  9:	  Cytokine	  Elicitation	  of	  THP-­‐1	  Cells	  by	  Positive	  Control	  (PMA)	  Over	  24	  
Hours	  Analyzed	  Using	  a	  Cytokine	  Bead	  Array	  and	  Flow	  Cytometry	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Figure 10: Cytokine Elicitation of THP-1 Cells by Commercial Chitosan 7 (DA 
61%) Analyzed Using a Cytokine Bead Array and Flow Cytometry 	  
 
Figure 11: Cytokine Elicitation of THP-1 Cells by Commercial Chitosan 8 (DA 
61%) Analyzed Using a Cytokine Bead Array and Flow Cytometry 	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Figure 12: Cytokine Elicitation of THP-1 Cells by Commercial Chitosan 9 (DA 
61%) Analyzed Using a Cytokine Bead Array and Flow Cytometry 
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CHAPTER 6 
DISCUSSION 
The primary hypothesis of this study, that chitin particles with a high degree of 
acetylation will elicit cytokines associated with a Th2-type immune response, is not 
currently supported. By replicating the processing methods and better characterizing the 
chitin preps with regard to degree of acetylation, I attempted to fill in gaps in other 
studies and gain a clearer picture of immunological response to chitin exposure.  
 My study indicates that autoclaving and sonication processing steps do not have a 
significant influence on degree of acetylation as suggested by various studies (No et al., 
2000; Muzzarelli, 2005; Sjoholm et al., 2000; Takahashi et al., 1994). Autoclaving does 
not have a statistically significant effect on degree acetylation when comparing the mean 
degrees of acetylation between autoclaved and un-autoclaved sonicated chitin samples 
(p>0.05). Sonication also did not reduce DA to the point of causing chitin to turn to 
chitosan, as evidenced by the average DA of the Shibata prep and the Da Silva prep being 
97.72 ± 0.59 and 98.33 ± 1.20, respectively, which included sonication steps. The 
physical treatments used in the Shibata and Da Silva methodology do not cause a drastic 
deacetylation, and the particles produced are chitin.  There is also not a statistically 
significant difference in DA between chitin sources, as comparing the DA of crab and 
shrimp chitin resulted in a p-value of 0.12076. Chitosan was markedly different to work 
with and sonication may have converted some of the chitosan into soluble monomers or 
dimers as there was a large reduction in yield of chitosan particles during processing. 
Analysis by flow cytometry indicated that the preparations used in this study, 
although replicating methodology of previous studies, had particle sizes below the 1.0µm 
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range that was frequently found in literature to be the lowest size limit tested for 
immunogenicity of chitin particles [Shibata et al. (1997a, 1997b, 2000, 2001); Strong and 
Clark (2002); Da Silva et al. (2008a); Kogiso et al. (2011)]. Overall particle size was well 
below the anticipated 1-10µm size distribution. This may have been due to 
oversonication, possibly resulting from use of a different size or shape of sonication 
vessel. Because ultrasonic energy is produced from the tip of the sonicator and directed 
downward, a large or wide vessel would result in less mixing and an overall decrease in 
the amount of sample being subjected to the treatment and subsequently produce a larger 
particle size. These results indicate that the parameters of sonication (time, intensity, and 
vessel size and shape) can significantly alter the distribution of chitin particle size and 
can easily skew it toward a much smaller size. The development of standardized 
protocols for the preparation of chitin particles in future studies must take this into 
account in achieving chitin particles of differing size ranges. 
My study makes a unique contribution by establishing that immunostimulatory 
effects can occur from particles at or <1µm in size. This is relevant to asthma and allergy 
as these particles are well within the respirable range (Brown et al., 2013). A 0.5µm 
particle can take upwards of 41 hours to settle five feet and in a turbulent environment 
may never settle (Baron, 2010). Chitin is present in several components of house dust 
including fungal cell walls, insect exoskeletons, and dust mite droppings (Nathan et al., 
2009; Van Dyken et al., 2011), therefore fragments of chitin may remain suspended 
indefinitely, and the likelihood of exposure to particles containing chitin within this size 
range is quite likely. 
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Although our cytokine analysis had a high variability, particles with a high degree 
of acetylation did not seem to elicit a Th2-type effector cytokine profile. The DA does 
seem to affect cytokine production/presence at later time points (12- through 24-hours), 
though I found that it is the mid-acetylated chitin/chitosan preparations that elicited the 
greatest cytokine response, particularly for IL-1β. Bueter et al. (2011) found that chitin 
microparticles elicited IL-1β at 6 hours in bone marrow-derived macrophages at 
concentrations of around 25 pg/ml and chitosan elicited concentrations around 75 pg/ml, 
whereas I found that at early time points, IL-1β concentrations were quite a bit lower in 
all samples. IL-1β production at later time points (18 and 24 hours) was at higher 
concentrations with the commercial chitosan (61% acetylated), which indicates that the 
THP-1 cell line has a greater response to mid-acetylated chitin with an initial Th1-like 
response that changes to a Th17-dominated response with the production of IL-1β 
(Acosta-Rodriguez et al., 2007). 
My results also indicate a change from a TNF-dominated response to an IL-1β-
dominated response, with IL-10 (a Th1 inhibitor) occurring at the 12-hour time point. 
The earliest time point is similar to results seen by Shibata (1997a) and Da Silva et al. 
(2009) with TNF production being dominant, however this changed over time. Da Silva 
et al. (2009) found that both TNF and IL-10 response was greatest at 6 and 18 hours, with 
peaks of 1500 pg/mL and 150 pg/mL, respectively, decreasing over 24 hours. This 
pattern was true for TNF release associated with all preparations except the fully 
acetylated (DA 100%), though the commercial chitosan (DA 61%) had the highest TNF 
elicitation (156 pg/mL) was almost a full order of magnitude less than what Da Silva et 
al. (2009) reported from peritoneal macrophages. I found that IL-10 peaked in chitin 
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samples (DA 100% and 97.7%) at 24 hours and 12 hours, respectively, also at a full 
magnitude lower than the response observed in Da Silva et al. (2009). Taken together, 
these results show that the magnitude of the initial Th1-type effector response of THP-1 
monocytic cells in response to chitin microparticle stimulation is of a much smaller 
magnitude than those in previous studies, and may be indicative of what happens very 
early on in the immune response associated with exposure to chitin and chitosan.  This is 
in agreement with the observations made by Lee et al. (2012) who found that monocytes 
exposed to Active Hexose Correlated Compound, a natural extract composed of 
oligosaccharides (including α- and β-glucans) produced IL-1β at 18 hours post-exposure. 
The results also indicate that in contrast to Bueter et al. (2011), the sample with 
the lowest DA was not the most immunologically active, rather it was the sample 
averaging 61% DA (Figures 3-7). While further work is needed to reduce variability in 
the cytokine analysis, we have remaining cell culture supernatant and additional cell 
culture response replicates such that this can be further refined. 
My study has created a dose-response curve of DA as compared to cytokine 
elicitation using preparations that were replicated as closely as could be achieved and 
then characterized for their DA, which has never been previously attempted. The results 
initially were similar to previous studies, though showed a tip toward the start of an IL-
1β-dominated Th17 effector response. This is likely a result of both degree acetylation 
and particle size, and cell type. This study also revealed that monocytes, the precursors to 
macrophages, are both activated by and elicit cytokines in response to chitin particles 
<1µm, indicating that chitin and chitosan fragments stimulate the innate immune system 
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to recruit antigen presenting cells and activate T lymphocytes in a Th17 manner, similar 
to the results seen in Lee et al. (2012).  
  Although this study addressed only the degree of acetylation of samples, there are 
several other characteristics of chitin and chitosan that may also influence its behavior, 
including protein and mineral content as well as its association with polysaccharides. 
Shibata et al. (1997b) found that chitin binds through the mannose receptor, and because 
N-glycans can have high concentrations of mannose (Kang et al., 2005), competitive 
binding may be occurring. Fully characterizing the preparations with polysaccharide 
composition as well as degree acetylation may provide fuller insight into the effects of 
various processing methods of chitin and chitosan as well as the immunologic response 
resulting from them. This may ultimately shed light onto some of the discrepancies 
between studies if there is a mechanism that is currently unaccounted for in the chitin and 
chitosan preparations currently being employed by researchers.  
 Future studies should also include the use of different cell lines, particularly the 
analysis of cytokine production by macrophages exposed to chitin and chitosan, as they 
are more likely to be exposed to chitin and chitosan in the lung. Studies involving cell co-
culture with an antigen presenting cell (such as a dendritic cell) and a CD4+ T-cell 
population would give a much better indication as to any T-helper cell polarization that 
results from exposure to chitin and chitosan.  
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APPENDIX A 	  
 SIZE DISTRIBUTION HISTOGRAMS 
 
  
 	  	  
 
 
 
 
Histogram 2: Acetylated Chitin 1 
Histogram 3: Acetylated Chitin 3 Histogram 4: Acetylated Chitin 4 
Histogram 5: Shibata Method 1 Histogram 6: Shibata Method 3 
Histogram 7: Shibata Method 4 Histogram 8: Partially Deacetylated Chitin 1 
Histogram 1: Acetylated Chitin 3 
 
 
 
 
54 
 	  	  
 
 
 
 	  
 
  
Histogram 9: Partially Deacetylated Chitin 3 
Histogram 15: Purified Chitosan 3 
Histogram 10: Partially Deacetylated Chitin 4 
Histogram 11: Commercial Chitosan 7 
Histogram 12: Commercial Chitosan 8 
Histogram 13: Commercial Chitosan 9 Histogram 14: Purified Chitosan 2 
Histogram 16: Purified Chitosan 4 
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APPENDIX B  
 
STANDARD CURVES FOR CYTOKINE ANALYSIS 
 
 
       Standard Curve: 1 TNF         Standard Curve: 2 IL-1β 
 
       Standard Curve: 3 IL-10         Standard Curve: 4 IL-6 
	  
       Standard Curve: 5 IFN-γ         Standard Curve: 6 GM-CSF 	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       Standard Curve: 7 IL-2          Standard Curve: 8 IL-4 	  
 
       Standard Curve: 9 IL-13         Standard Curve: 10 IL-12p70 	  
 
       Standard Curve: 11 IL-17a          
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